Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 03 1997, 679-684, Vol 35, No. 3
RB Westerman, Y He, JE Keen, ET Littledike and J Kwang
Identification of the O157 antigen is an essential part of the detection of
Escherichia coli O157:H7, which is recognized as a major etiologic agent of
hemorrhagic colitis. However, polyclonal antibodies produced against E.
coli O157:H7 lipopolysaccharide (LPS) may react with several other bacteria
including Brucella abortus, Brucella melitensis, Yersinia enterocolitica
O9, Escherichia hermannii, and Stenotrophomonas maltophilia. We produced
eight monoclonal antibodies (MAbs) specific for the LPS of E. coli O157.
Western blots (immunoblots) of both the phenol phase (smooth) and the
aqueous phase (rough) of hot phenol-water-purified LPS indicated that three
of the MAbs were specific for the O antigen and five were reactive with the
LPS core. The eight MAbs could be further differentiated by their
reactivities to Salmonella O30 LPS (group N), which is reported to be
identical to the E. coli O157 antigen. All eight MAbs reacted strongly to
all of the 64 strains of E. coli O157 tested, which included 47 isolates of
O157:H7 and 17 other O157 strains. None of the eight MAbs cross-reacted
with any of the 38 other E. coli serotypes tested, which consisted of 29
different O-antigen serotypes, or with 38 strains (22 genera) of non-E.
coli gram-negative enteric bacteria.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Production and characterization of monoclonal antibodies specific for the lipopolysaccharide of Escherichia coli O157
U.S. Meat Animal Research Center, Agricultural Research Service, U.S. Department of Agriculture, Clay Center, Nebraska 68933, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|